New drugs in multiple myeloma and the significance of autologous stem cell transplants
Jagannath, S.
Clinical Advances in Hematology and Oncology H&o 7(3): 178-179
2009
ISSN/ISBN: 1543-0790 PMID: 19398940 Document Number: 628390
Document emailed within 1 workday
Related Documents
Jagannath, S.; Vesole, D.H.; Tricot, G.; Crowley, J.; Salmon, S.E.; Barlogie, B. 1994: Hemopoietic stem cell transplants for multiple myeloma Oncology 8(11): 89Harousseau, J.L.; Attal, M. 1997: The role of autologous hematopoietic stem cell transplantation in multiple myeloma Seminars in Hematology 34(1 Suppl 1: 61-66
Kumar, L.; Boya, R.R.; Pai, R.; Harish, P.; Mookerjee, A.; Sainath, B.; Patekar, M.B.; Sahoo, R.K.; Malik, P.S.; Sharma, O.D.; Gupta, R. 2016: Autologous stem cell transplantation for multiple myeloma: Long-term results National Medical Journal of India 29(4): 192-199
Erkus, M.; Bolaman, Z.; Meteoglu, I.; Kadikoylu, G. 2005: Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma Saudi Medical Journal 26(6): 989-991
Voorhees, P.M.; Usmani, S.Z. 2016: The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy Clinical Advances in Hematology and Oncology: H&o 14(9): 719-728
Alegre, Aán.; Granda, Aón.; Martínez-Chamorro, C.; Díaz-Mediavilla, Jín.; Martínez, R.; García-Laraña, Jé.; Lahuerta, J-José.; Sureda, A.; Bladé, J.; de la Rubia, J.; Fernández-Rañada, Jé.Maria.; San Miguel, Jús. 2002: Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry Haematologica 87(6): 609-614
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Patriarca, F.; Gaidano, G.; Capello, D.; Zaja, F.; Fanin, R.; Baccarani, M. 2000: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation Haematologica 85(9): 982-985
Mohammadi, L.; Harir, N.; Brahimi, M.; Moulessehoul, S.; Bekadja, M.Amine. 2017: Epidemiological, clinical and pronostic aspects of multiple myeloma eligible for therapeutic intensification followed by autologous hematopoietic stem cell in the Algerian West: report of 147 cases La Tunisie Medicale 95(6): 415-421
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Henon, P.R.; Liang, H.; Beck-Wirth, G.; Eisenmann, J.C.; Lepers, M.; Wunder, E.; Kandel, G. 1992: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants Bone Marrow Transplantation 9(4): 285-291
Pileri, A.; Tarella, C.; Bregni, M.; Boccadoro, M.; Siena, S.; Caracciolo, D.; Bonadonna, G.; Gianni, A.M. 1990: GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma Haematologica 75(Suppl 1): 79-82
Fragonas, E.; Perticarari, S.; Presani, G.; Rabusin, M.; Andolina, M.; Mangiarotti, M.A. 2000: In vitro incubation of bone marrow and peripheral stem cells with vincristine and methylprednisolone: functional T-cell depletion for haploidentical and autologous transplants Haematologica 85(11 Suppl): 86-88
Bandinelli, F.; Saccardi, R.; Salvadorini, G.; Bosi, A.; Gozzini, A.; Matucci Cerinic, M. 2013: Stiff skin syndrome and myeloma successfully treated with autologous haematopoietic stem cell transplantation (HSCT) Clinical and Experimental Rheumatology 31(2 Suppl 76: 181-183
Fukuda, S.; Sunami, K.; Sezaki, T. 1999: Stem cell transplantation in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1407-1414
Barlogie, B. 1993: Hemopoietic stem cell transplant for multiple myeloma (MM) Leukemia 7(7): 1095
Takase, K.; Miyamoto, T. 2015: Allogeneic hematopoietic stem cell transplantation for multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 73(1): 107-113
Gertz, M.A.; Pineda, A.A.; Chen, M.G.; Letendre, L.; Greipp, P.R.; Solberg, L.A.; Witzig, T.E.; Garton, J.P.; Inwards, D.J.; Litzow, M.R. 1995: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation American Journal of the Medical Sciences 309(3): 152-161
Subbiah, S.; O'Connell, F.; Kobraei, K.B.; Ramos-Caro, F.A.; Moreb, J.S. 2009: Unusual multiple myeloma cutaneous manifestation following nonmyeloablative allogeneic stem cell transplantation Clinical Advances in Hematology and Oncology: H&o 7(12): 800-802
Krejcí, M.; Hájek, R.; Korístek, Z.; Krivanová, A.; Navrátil, M.; Adam, Z. 2000: Haematopoietic stem cell mobilization in patients with multiple myeloma--comparison of 3 variations of the stimulating regime Vnitrni Lekarstvi 46(8): 439-443